ArticleOphthalmology and therapy2024

One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration.

Giuseppe Cancian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.